Head
neck
squamous
cell
carcinoma
(
HNSCC
)
sixth
common
cancer
world
600,000
new
cases
diagnosed
annually
.

Tobacco
alcohol
use
associated
principal
etiological
factors
pathogenesis
.

The
incidence
smoking-associated
HNSCC
declined
,
human
papilloma
virus
(
HPV
)
-associated
HNSCC
rise
.

There
currently
clinically
validated
biomarkers
detect
cancer
early
stage
(
cancers
independent
HPV
status
)
.

It
well-established
aberrant
expression
miRNAs
lead
tumorigenesis
.

miRNA
expression
differences
also
demonstrated
HPV-positive
HPV-negative
HNSCC
tumor
tissues
well
body
fluids
.

Therefore
,
miRNAs
potential
provide
unprecedented
insight
pathogenesis
HNSCC
serve
potential
biomarkers
.

This
review
addresses
HNSCC
disease
burden
regulation
miRNA
HPV
viral
oncoproteins
,
potential
miRNA
biomarkers
future
perspectives
.

miRNA
provides
unique
opportunity
fulfill
current
clinical
challenge
HNSCC
patient
management
enabling
early
detection
followed
targeted
interventions
,
leading
significant
reduction
mortality
morbidity
.

